Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2018	Dec. 31, 2017
Current assets
Cash and equivalents	$ 2,947	$ 3,394
Accounts and other current receivables, net	1,807	1,793
Inventories	1,581	1,475
Prepaid expenses and other	621	601
Total current assets	6,956	7,263
Property, plant and equipment, net	4,614	4,588
Other assets
Goodwill	3,107	3,099
Other intangible assets, net	1,507	1,374
Other	706	787
Total other assets	5,320	5,260
Total assets	16,890	17,111
Current liabilities
Current maturities of long-term debt and lease obligations	3	3
Accounts payable and accrued liabilities	2,533	2,733
Current income taxes payable	106	85
Total current liabilities	2,642	2,821
Long-term debt and lease obligations	3,550	3,509
Other long-term liabilities	1,605	1,665
Equity
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2018 and 2017	683	683
Common stock in treasury, at cost, 146,993,164 shares in 2018 and 142,017,600 shares in 2017	(8,354)	(7,981)
Additional contributed capital	5,912	5,940
Retained earnings	14,734	14,483
Accumulated other comprehensive (loss) income	(3,876)	(4,001)
Total Baxter shareholders’ equity	9,099	9,124
Noncontrolling interests	(6)	(8)
Total equity	9,093	9,116
Total liabilities and equity	$ 16,890	$ 17,111